Evidence for successive peptide binding and quality control stages during MHC class I assembly

Current Biology

Volumn 8, Issue 12, 1998, Pages 717-721

  Lewis, Jonathan W ^a   Elliott, Tim ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032482319     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0960-9822(98)70280-5     Document Type: Article

References (18)

1. Heemels MT, Ploegh H: Generation, translocation, and presentation of MHC class I-restricted peptides. Annu Rev Biochem 1995, 64:463-491.
2. Sadasivan B, Lehner PJ, Ortmann B, Spies T, Cresswell P: Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 1996, 5:103-114.
3. Lewis JW, Neisig A, Neefjes J, Elliott T: Point mutations in the α2 domain of HLA-A2.1 define a functionally relevant interaction with TAP. Curr Biol 1996, 6:873-883.
4. Rodan AR, Simons JF, Trombetta ES, Helenius A: N-linked oligosaccharides are necessary and sufficient for association of glycosylated forms of bovine RNase with calnexin and calreticulin. EMBO J 1996, 15:6921-6930.
5. Hebert DN, Foellmer B, Helenius A: Calnexin and calreticulin promote folding, delay oligomerization and suppress degradation of influenza hemagglutinin in microsomes. EMBO J 1996, 15:2961-2968.
6. Krause KH, Michalak M: Calreticulin. Cell 1997, 88:439-443.
7. Helenius A, Trombetta ES, Hebert DN, Simons JF: Calnexin, calreticulin and the folding of glycoproteins. Trends Cell Biol 1997, 7:193-200.
8. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC: Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987, 329:506-512.
9. Kelly A, Powis SH, Kerr LA, Mockridge I, Elliott T, Bastin J, et al.: Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex. Nature 1992, 355:641-644.
10. Snyder HL, Yewdell JW, Bennink JR: Trimming of antigenic peptides in an early secretory compartment. J Exp Med 1994, 180:2389-2394.
11. Elliott T, Willis A, Cerundolo V, Townsend A: Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum. J Exp Med 1995, 181:1481-1491.
12. Sijts AJ, Pamer EG: Enhanced intracellular dissociation of major histocompatibility complex class I-associated peptides: a mechanism for optimizing the spectrum of cell surface-presented cytotoxic T lymphocyte epitopes. J Exp Med 1997, 185:1403-1411.
13. Kropshofer H, Hammerling GJ, Vogt AB: How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest? Immunol Today 1997, 18:77-82.
14. Kropshofer H, Vogt AB, Moldenhauer G, Hammer J, Blum JS, Hammerling GJ: Editing of the HLA-DR-peptide repertoire by HLA-DM. EMBO J 1996, 15:6144-6154.
15. Vogt AB, Kropshofer H, Moldenhauer G, Hammerling GJ: Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM. Proc Natl Acad Sci USA 1996, 93:9724-9729.
16. Denzin LK, Cresswell P: HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 1995, 82:155-165.
17. Parham P, Brodsky FM: Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. Hum Immunol 1981, 3:277-299.
18. Parham P, Barnstable CJ, Bodmer WF: Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens. J Immunol 1979, 123:342-349.